PRESS RELEASE

Published September 28, 2023

The latest report by IMARC Group, titled “Bronchodilators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the global bronchodilators market size. The report also includes competitor and regional analysis, and contemporary advancements in the market. 

The global bronchodilators market size reached US$ 35.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 48.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2023-2028.

Global Bronchodilators Market Overview:

A bronchodilator is a medical substance or medication designed to alleviate symptoms of respiratory conditions by dilating or enlarging the air passages within the lungs, known as bronchi and bronchioles. These conditions, frequently marked by respiratory challenges and the narrowing of air passages, encompass ailments such as asthma, chronic obstructive pulmonary disease, and other chronic lung disorders. Bronchodilators function by relaxing the smooth muscles encircling the airways, facilitating their expansion and enhancing the flow of air in and out of the lungs. Typically, bronchodilators are administered using inhalation devices like metered-dose inhalers or nebulizers. This localized delivery method ensures swift symptom relief while minimizing systemic side effects.

Get a Sample Copy of the Report at:  https://www.imarcgroup.com/bronchodilators-market/requestsample

Global Bronchodilators Market Trends:

The global market is primarily driven by the growing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. The increasing global burden of these conditions has led to a growing demand for effective bronchodilator medications that can provide quick relief to patients experiencing breathing difficulties. Moreover, factors like urbanization, increased air pollution, and shifts in lifestyle have played a role in the rising prevalence of respiratory problems, thereby driving the demand for bronchodilators. Ongoing advancements in medical technology and pharmaceutical research have resulted in the introduction of innovative bronchodilator formulations that offer enhanced effectiveness and reduced side effects, adding momentum to the market's growth. Furthermore, the aging population, which is more susceptible to respiratory conditions, is contributing to the market's expansion as elderly individuals turn to bronchodilators to manage their symptoms and improve their overall quality of life.

Explore the Full Report with Charts, Table of Contents, and List of Figures:www.imarcgroup.com/bronchodilators-market

Competitive Landscape with Key Players:

The competitive landscape of the industry has also been examined along with the profiles of the key players being

  • Abbott Laboratories
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Novartis AG, Pfizer Inc
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • Vectura Group plc

Breakup by Indication:

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Others

Breakup by Drug Type:

  • Sympathomimetics
  • Anticholinergics
  • Phosphodiesterase Inhibitor
  • Combination Drugs

Breakup by Route of Administration:

 Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, and others)

Key Highlights of the Report:

  • Market Performance
  • Market Outlook
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company’s expertise.

Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Source link